Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by PAREXEL. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PAREXEL or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Is there room for new COAs in neuroscience?

28:32
 
Share
 

Manage episode 468316574 series 2618437
Content provided by PAREXEL. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PAREXEL or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

As we strive to improve health outcomes for patients with neurological conditions, the development of new clinical outcomes assessments (COAs) is crucial. Advancements in COAs are at a tipping point, significantly impacting the future of clinical trials and patient care.

Our clinical development and regulatory experts discuss the importance of developing new COAs to better capture the full spectrum of patient experiences, particularly in conditions like multiple sclerosis (MS). With MS as a focal point, our experts highlight the gaps in current assessments and

In this episode, Andreas Lysandropoulos, Naomi Suminski, and Simona Stankeviciute share insights on the evolving understanding of neurological conditions and the hidden problems that current COAs may overlook. They emphasize the importance of patient-centered research and the role of early and strategic planning in regulatory success. Pushing the boundaries with innovative approaches to COAs in neuroscience we can ensure that clinical trials reflect meaningful changes in patients’ lives.

  continue reading

54 episodes

Artwork
iconShare
 
Manage episode 468316574 series 2618437
Content provided by PAREXEL. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PAREXEL or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

As we strive to improve health outcomes for patients with neurological conditions, the development of new clinical outcomes assessments (COAs) is crucial. Advancements in COAs are at a tipping point, significantly impacting the future of clinical trials and patient care.

Our clinical development and regulatory experts discuss the importance of developing new COAs to better capture the full spectrum of patient experiences, particularly in conditions like multiple sclerosis (MS). With MS as a focal point, our experts highlight the gaps in current assessments and

In this episode, Andreas Lysandropoulos, Naomi Suminski, and Simona Stankeviciute share insights on the evolving understanding of neurological conditions and the hidden problems that current COAs may overlook. They emphasize the importance of patient-centered research and the role of early and strategic planning in regulatory success. Pushing the boundaries with innovative approaches to COAs in neuroscience we can ensure that clinical trials reflect meaningful changes in patients’ lives.

  continue reading

54 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play